Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report
International Journal of Dermatology · 2026-08-12
DOI: 10.1111/ijd.70632 ↗At a glance
Leserbrief in International Journal of Dermatology, published online on 2026-08-12. Written by Selcen Hoşgören-Tekin and 3 co-authors. Institution: Marmara Universitesi Tip Fakultesi, Istanbul, Türkiye. 5 references.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
Author keywords
Authors and institutions
- Marmara Universitesi Tip Fakultesi, Istanbul, Türkiye.
ORCID profiles: Selcen Hoşgören-Tekin, Ahmet Atas, Dilek Seçkin, Ayşe Deniz Yücelten
Cite
APA
Hoşgören-Tekin, S., Atas, A., Seçkin, D., & Yücelten, A. D. (2026). Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report. International Journal of Dermatology. https://doi.org/10.1111/ijd.70632
Vancouver
Hoşgören-Tekin S, Atas A, Seçkin D, Yücelten AD. Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report. International Journal of Dermatology. 2026. doi:10.1111/ijd.70632
BibTeX
@article{HogrenTekin2026,
author = {Hoşgören-Tekin, Selcen and Atas, Ahmet and Seçkin, Dilek and Yücelten, Ayşe Deniz},
title = {Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70632}
}
EUVIMED